Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose

P Rigo, P Paulus, BJ Kaschten, R Hustinx… - European journal of …, 1996 - Springer
Positron emission tomography (PET) is now primarily used in oncological indication owing
to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing …

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas: the cumulative …

AMM Eggermont, HS Koops, JM Klausner… - Annals of …, 1996 - journals.lww.com
Objective The objective of the study was to achieve limb salvage in patients with locally
advanced soft tissue sarcomas that can only be treated by amputation or functionally …

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue …

AM Eggermont, H Schraffordt Koops… - Journal of Clinical …, 1996 - ascopubs.org
PURPOSE To determine the efficacy of isolated limb perfusion (ILP) with tumor necrosis
factor-alpha (TNF) in combination with interferon-gamma (IFN) and melphalan as induction …

(F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma

AL Folpe, RH Lyles, JT Sprouse, EU Conrad III… - Clinical cancer …, 2000 - AACR
Positron emission tomography (PET) can be used to measure tumor metabolism in
sarcomas by measuring the standard uptake value (SUV) of (F-18) fluorodeoxyglucose …

Value of FDG PET/CT in patient management and outcome of skeletal and soft tissue sarcomas

S Sheikhbahaei, C Marcus, N Hafezi-Nejad… - PET clinics, 2015 - pet.theclinics.com
Bone and soft tissue sarcomas are a heterogeneous group of relatively rare tumors. 1, 2 The
incidence of bone and soft tissue tumors has increased during the last 35 years. In the …

Positron emission tomography with 2-[18F]-fluoro-2-deoxy-d-glucose in oncology: Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and …

MPM Stokkel, A Draisma, EKJ Pauwels - Journal of cancer research and …, 2001 - Springer
Positron emission tomography (PET) using 18F-fluorodeoxyglucose (FDG) is considered to
be a very useful adjunct to anatomic imaging techniques and is now primarily used for …

Isolated limb perfusion in primary and recurrent melanoma: indications and results

D Liénard, AM Eggermont, BBR Kroon… - Seminars in surgical …, 1998 - Wiley Online Library
In advanced melanoma of the limbs with in‐transit metastasis, melphalan with isolated limb
perfusion (M‐ILP) produces around 50% complete remissions (CR). The combination of …

Size-based clinical response evaluation is insufficient to assess clinical response of sarcomas treated with isolated limb perfusion with TNF-α and melphalan

F Grabellus, E Stylianou, L Umutlu, SY Sheu… - Annals of surgical …, 2012 - Springer
Background The clinical assessment of the response of sarcomas to preoperative treatment
is usually defined using size-based evaluation standards. For nonresectable sarcomas …

Bone marrow uptake of fluorine-18-fluorodeoxyglucose following treatment with hematopoietic growth factors: initial evaluation

MV Knopp, H Bischoff, A Rimac, F Oberdorfer… - Nuclear medicine and …, 1996 - Elsevier
Hematopoietic growth factors (HGF) such as G-CSF and GM-CSF stimulate cell growth of the
bone marrow and thereby mitigate the myelotoxic effect of chemotherapy. Using 18F-fluoro …

Current update on the diagnosis and management of head and neck soft tissue sarcomas

B Tudor‐Green, R Gomez… - Journal of Oral Pathology …, 2017 - Wiley Online Library
Head and neck soft tissue sarcomas are a group of rare heterogeneous tumours arising from
embryonic mesoderm. They comprise< 1% of all head and neck malignancies and 5–15% of …